Concepedia

Duuamene Nyimanu

DN

12

Publications

1.1K

Citations

11

H-Index

2019

Active since

Affiliations

University of Cambridge(Current)

Addenbrooke's Hospital

Imperial College London

University of Edinburgh

University College London

Duuamene Nyimanu is an author at University of Cambridge specializing in quantitative pharmacology, molecular physiology, and drug discovery.

ORCID

Top concepts

Publications per year

2019–2023

12

Publications

12

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

S P H Alexander, Arthur Christopoulos, Anthony P. Davenport et al. · British Journal of Pharmacology · 2021 · 479 citations · Full text

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors

S P H Alexander, Arthur Christopoulos, Anthony P. Davenport et al. · British Journal of Pharmacology · 2023 · 379 citations · Full text

, , +16

A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension

Peiran Yang, Cai Read, Rhoda E. Kuc et al. · British Journal of Pharmacology · 2019 · 41 citations · Full text

Enhanced selectivity, cellular uptake, and <i>in vitro</i> activity of an intrinsically fluorescent copper–tirapazamine nanocomplex for hypoxia targeted therapy in prostate cancer

Vera L. Silva, Abdessamad Y. A. Kaassis, Ashkan Dehsorkhi et al. · Biomaterials Science · 2020 · 21 citations · Full text

The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo

Cai Read, Duuamene Nyimanu, Peiran Yang et al. · Frontiers in Pharmacology · 2021 · 20 citations · Full text

Rows per page

1–5 of 12